United States:
FDA Announces Renewal Of Nonprescription Drugs Advisory Committee
24 September 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the September 3, 2015, Federal Register, FDA
announced the renewal of the Nonprescription Drugs Advisory
Committee by the FDA Commissioner. The committee is being renewed
for an additional two years beyond the charter expiration date.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
